Asthma Mgmt Week 7 Slide 11 04.14

Haley's asthma symptoms are persistent, so she needs a change in treatment. The next step is to start using a controller therapy, which can be an inhaled corticosteroid alone or with a long-acting beta agonist if necessary. Albuterol is a short-acting beta agonist, fluticasone is an inhaled corticosteroid, and formiderol is a long-acting beta agonist. Combination inhalers can contain fluticasone and salmiderol. Montelukast is a leukotriene receptor agonist, and omalizumab is a biological therapy. Treatment slash medications. Given Haley's persistent asthma symptoms and increased SABA use, stepping up her treatment to achieve better control is necessary. The next step in her management would involve initiating controller therapy with an inhaled corticosteroid either as a monotherapy or in combination with a long-acting beta agonist, LABA, if needed. Short-acting beta agonists, SABAs, is albuterol. Inhaled corticosteroids is fluticasone. Long-acting beta agonists may be formiderol. Combination inhalers, ICS slash LABAs, can be fluticasone and salmiderol. Leukotriene receptor agonist is montelukast. And biological therapies can be omalizumab.